$5.80
-0.16-2.68%
In chiusura: -
$6.00
0.203.45%
After hour: Oct 31, 5:22 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Karyopharm Therapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 3
Stima EPS
$-3.270
Stima dei ricavi trimestrali
$42.37M
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$137.27M
Analizza lo storico degli utili di Karyopharm Therapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
KPTI | Karyopharm Therapeutics | -$3.90 | -$3.27 | — | — | $38.78M | $42.37M | — | — | 11/03/2025 | |
KPTI | Karyopharm Therapeutics | -$2.97 | -$3.86 | -$4.32 | -11.92% | $42.79M | $38.79M | $37.93M | -2.21% | 08/11/2025 | |
KPTI | Karyopharm Therapeutics | -$4.85 | -$3.09 | -$2.77 | 10.36% | $33.13M | $35.12M | $30.02M | -14.54% | 05/12/2025 | |
KPTI | Karyopharm Therapeutics | -$5.40 | -$4.05 | -$3.60 | 11.11% | $33.75M | $35.67M | $30.54M | -14.38% | 02/19/2025 | |
KPTI | Karyopharm Therapeutics | -$4.50 | -$3.90 | -$3.90 | 0.00% | $36.01M | $37.79M | $38.78M | 2.63% | 11/05/2024 | |
KPTI | Karyopharm Therapeutics | -$4.35 | -$4.50 | -$3.00 | 33.33% | $37.58M | $36.18M | $42.79M | 18.26% | 08/06/2024 | |
KPTI | Karyopharm Therapeutics | -$4.50 | -$4.95 | -$4.80 | 3.03% | $38.70M | $34.47M | $33.13M | -3.90% | 05/08/2024 | |
KPTI | Karyopharm Therapeutics | -$6.45 | -$4.65 | -$5.40 | -16.13% | $33.58M | $35.40M | $33.75M | -4.67% | 02/29/2024 | |
KPTI | Karyopharm Therapeutics | -$6.75 | -$4.20 | -$4.50 | -7.14% | $36.15M | $37.28M | $36.01M | -3.41% | 11/02/2023 | |
KPTI | Karyopharm Therapeutics | -$9.30 | -$5.10 | -$4.35 | 14.71% | $39.68M | $36.23M | $37.58M | 3.72% | 08/02/2023 | |
KPTI | Karyopharm Therapeutics | -$7.95 | -$5.55 | -$4.50 | 18.92% | $47.67M | $36.60M | $38.70M | 5.73% | 05/04/2023 | |
KPTI | Karyopharm Therapeutics | $6.90 | -$5.25 | -$6.45 | -22.86% | $126.27M | $35.12M | $33.58M | -4.38% | 02/15/2023 | |
KPTI | Karyopharm Therapeutics | -$10.35 | -$8.55 | -$6.75 | 21.05% | $37.69M | $34.56M | $36.15M | 4.59% | 11/03/2022 | |
KPTI | Karyopharm Therapeutics | -$10.65 | -$9.45 | -$9.30 | 1.59% | $22.60M | $35.59M | $39.68M | 11.49% | 08/04/2022 | |
KPTI | Karyopharm Therapeutics | -$11.55 | -$9.45 | -$7.95 | 15.87% | $23.26M | $34.17M | $47.67M | 39.51% | 05/05/2022 | |
KPTI | Karyopharm Therapeutics | -$8.85 | -$7.35 | $6.90 | 193.88% | $35.10M | $50.49M | $126.27M | 150.09% | 02/08/2022 | |
KPTI | Karyopharm Therapeutics | -$10.95 | -$10.05 | -$10.35 | -2.99% | $21.33M | $25.80M | $37.69M | 46.08% | 11/03/2021 | |
KPTI | Karyopharm Therapeutics | -$9.45 | -$11.10 | -$10.65 | 4.05% | $33.51M | $25.64M | $22.60M | -11.85% | 08/05/2021 | |
KPTI | Karyopharm Therapeutics | -$11.70 | -$10.65 | -$11.55 | -8.45% | $18.14M | $25.17M | $23.26M | -7.59% | 05/03/2021 | |
KPTI | Karyopharm Therapeutics | -$11.40 | -$0.59 | -$8.85 | -1400.00% | $18.10M | $29.37M | $35.10M | 19.51% | 02/11/2021 | |
KPTI | Karyopharm Therapeutics | -$10.05 | -$10.80 | -$10.95 | -1.39% | $13.15M | $21.45M | $21.33M | -0.55% | 11/02/2020 |
Karyopharm Therapeutics (KPTI) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $-4.32 | $-3.86 | -11.9 % |
| Q1 | 2025-05-12 | $-2.77 | $-3.09 | 10.4 % |
| Q4 | 2025-02-19 | $-3.60 | $-4.05 | 11.1 % |
| Q3 | 2024-11-05 | $-3.90 | $-3.90 | 0.00 % |
Karyopharm Therapeutics (KPTI) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-11 | $37.93M | $38.79M | -2.21 % |
| Q1 | 2025-05-12 | $30.02M | $35.12M | -14.5 % |
| Q4 | 2025-02-19 | $30.54M | $35.67M | -14.4 % |
| Q3 | 2024-11-05 | $38.78M | $37.79M | 2.63 % |
FAQ
Quando Karyopharm Therapeutics (NASDAQ:KPTI) riporterà gli utili?
Si prevede che Karyopharm Therapeutics (KPTI) fornisca risultati il novembre 3, 2025. Gli ultimi risultati sono stati pubblicati il agosto 11, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Karyopharm Therapeutics (NASDAQ:KPTI)?
L'EPS effettivo era $-4.32, che mancato la stima di $-3.86.
Quali sono state le entrate di Karyopharm Therapeutics (NASDAQ:KPTI)?
Le entrate effettive sono state $37.9M, che mancato la stima di $38.8M.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.